Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
ADVAXIS RG (NQ: ADXS)
1.340 USD  +0.120 (+9.84%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 13, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 6,993,431
Open 1.220
Bid (Size) 1.310 (13900)
Ask (Size) 1.320 (100)
Prev. Close 1.220
Today's Range 1.300 - 1.620
52wk Range 1.150 - 7.449
Shares Outstanding 52,621,490
Dividend Yield N/A
Performance
YTD
-56.77%
-56.77%
1 Month
-20.71%
-20.71%
3 Month
-23.86%
-23.86%
6 Month
-54.11%
-54.11%
1 Year
-80.88%
-80.88%
Top News
More News
New Research Coverage Highlights Knowles, Advaxis, G-III Apparel Group, LTD, National CineMedia, Haemonetics, and MACOM Technology Solutions — Consolidated Revenues, Company Growth, and Expectations f
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Knowles Corporation... Read More
from GlobeNewswire News Releases
Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of Axalimogene Filolisbac with Durvalumab
Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced that the U.S. Food and Drug... Read More
from Business Wire News Releases
More News
Read More
Advaxis Provides Update on MAA Filing and ADXS-HOT Program
from Business Wire News Releases
Advaxis Shares Soar After FDA Lifts Clinical Hold On Cancer Drug
category Market News , News , ADXS , and 4 more.
from Benzinga
Advaxis Announces Dosing of First Patient with ADXS-NEO, an Investigational Customized Immunotherapy Approach Targeting Personal Neoantigens
from Business Wire News Releases
Traders Get Bullish on Shares of Advaxis Inc, Shares Up 26.0% (ADXS)
from Comtex SmarTrend® News Briefs
Advaxis Announces Prioritization of Product Portfolio and Reports Fiscal 2018 Second Quarter Financial Results
from Business Wire News Releases
Advaxis Inc: New 52-Week Low Set Today (ADXS)
from Comtex SmarTrend® News Briefs
10 Biggest Price Target Changes For Wednesday
category Market News , GLMD , HSY , and 15 more.
from Benzinga
30 Stocks Moving In Friday's Mid-Day Session
category IZEA , Trading Ideas , WWE , and 38 more.
from Benzinga
Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering
category Trading Ideas , SLS , Market News , and 32 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.